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gp91phox/NOX2We have previously demonstrated that a stable synthetic analog of 20-hydroxyeicosatetraenoic acid (20-
HETE), N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine (5,14-HEDGE), prevents vascular hyporeactivity,
hypotension, tachycardia, and inﬂammation in rats treated with lipopolysaccharide (LPS) and mortality
in endotoxemic mice. These changes were attributed to decreased production of inducible nitric oxide
(NO) synthase (iNOS)-derived NO, cyclooxygenase (COX)-2-derived vasodilator prostanoids, and proin-
ﬂammatory mediators associated with increased cyctochrome P450 (CYP) 4A1-derived 20-HETE and
CYP2C23-dependent antiinﬂammatory mediator formation. The aim of this study was to determine
whether decreased expression and activity of iNOS, soluble guanylyl cyclase (sGC), protein kinase G
(PKG), COX-2, gp91phox (NOX2; a superoxide generating NOX enzyme), and peroxynitrite production
associated with increased expression of COX-1 and CYP4A1 and 20-HETE formation in renal and cardio-
vascular tissues of rats contributes to the effect of 5,14-HEDGE to prevent vasodilation, hypotension,
tachycardia, and inﬂammation in response to systemic administration of LPS. Mean arterial pressure fell
by 28 mmHg and heart rate rose by 47 beats/min in LPS (10 mg/kg, i.p.)-treated rats. Administration of
LPS also increased mRNA and protein expression of iNOS and COX-2 associated with a decrease in
COX-1 and CYP4A1 mRNA and protein expression. Increased NOS activity, iNOS-heat shock protein 90
complex formation (an index for iNOS activity), protein expression of phosphorylated vasodilator stimu-
lated phosphoprotein (an index for PKG activity), gp91phox, p47phox (NOXO2; organizer subunit of
gp91phox), and nitrotyrosine (an index for peroxynitrite production) as well as cGMP (an index for sGC
activity), 6-keto-PGF1a (a stable metabolite PGI2) and PGE2 levels (indexes for COX activity), and
nitrotyrosine levels by LPS were also associated with decreased CYP hydroxylase activity as measured
by 20-HETE formation from arachidonic acid in renal microsomes of LPS-treated rats. These effects of
LPS, except iNOS mRNA and COX-1 protein expression, were prevented by 5,14-HEDGE (30 mg/kg,
s.c.; 1 h after LPS). A competitive antagonist of vasoconstrictor effects of 20-HETE, 20-hydroxyeicosa-6(Z),yeicosa-
uanosine
ric oxide
ric oxide
n kinase
in; PKG,
sly; sEH,
410605.
Fig. 1. Time course of the effects of 5,14-HEDGE and
conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20
animals. aSigniﬁcant difference from the correspondin
the rats treated with LPS (p < 0.05). cSigniﬁcant differe
from the time 0 h value within a group (p < 0.05). eSi
B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41 1915(Z)-dienoic acid (30 mg/kg, s.c.; 1 h after LPS) reversed the effects of 5,14-HEDGE, except iNOS and
COX-1 mRNA and protein expression as well as expression of CYP4A1 mRNA. These results suggest that
increased CYP4A1 expression and 20-HETE formation associated with suppression of iNOS/sGC/PKG
pathway, COX-2, and gp91phox participate in the protective effect of 5,14-HEDGE against vasodilation,
hypotension, tachycardia, and inﬂammation in the rat model of septic shock.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. Introduction
The expression of inducible nitric oxide (NO) synthase (iNOS) is
enhanced in many tissues in response to mediators released by the
lipid A part of lipopolysaccharide (LPS), also known as endotoxin,
which is the most potent microbial mediator in the pathogenesis
of septic shock [1]. This leads to increased generation of NO, which
contributes to a fall in blood pressure, vascular hyporeactivity,
multiple organ failure, and high mortality rate that are associated
with septic shock [1]. In many models, endotoxin-induced vascular
hyporeactivity to vasoconstrictors is associated with an enhanced
formation of NO within the blood vessels, involving activation of
not only iNOS, but also endothelial NOS (eNOS) [2]. NO is a potent
activator of soluble guanylyl cyclase (sGC) and exerts many of its
effects by activating sGC, which produces cyclic guanosine mono-
phosphate (cGMP) [3]. NO plays an important role in cGMP-medi-
ated smooth muscle relaxation by activating protein kinase G
(PKG) leading to phosphorylation of vasodilator stimulated phos-
phoprotein (VASP) [4,5]. NO also reacts with superoxide generated
by mainly gp91phox (also known as NOX2) in the presence of
p47phox (also known as NOXO2; organizer subunit of gp91phox) to
form peroxynitrite, a powerful oxidant and nitrating molecule,20-HEDE on (A) MAP and (B) HR
-HEDE (30 mg/kg, s.c.) were given
g value seen in rats treated with sa
nce from the corresponding value
gniﬁcant difference from the timeand subsequent reaction of peroxynitrite with proteins results in
nitrotyrosine formation [6,7]. In vivo, peroxynitrite generation rep-
resents a NO-dependent pathogenic mechanism in conditions such
as circulatory shock and chronic inﬂammatory diseases. In addition
to NO, increased production of prostanoids by cyclooxygenase
(COX)-2 has also been shown to contribute to systemic hypoten-
sion and related organ damage and decreased survival in animals
and humans with sepsis [1]. Systemic blockade of iNOS or COX-2
opposes the fall in blood pressure in sepsis and septic shock [1].
This is not only due to withdrawal of the vasodilator effects of
NO and prostanoids, but also associated with enhanced production
of vasoconstrictor mediators including catecholamines, endothe-
lin-1, and 20-hydroxyeicosatetraenoic acid (20-HETE) as well as
activation of the renin-angiotensin system and increased sensitiv-
ity of baroreceptor reﬂex mechanisms [1].
20-HETE is anx-hydroxylation product of arachidonic acid (AA)
that is produced by cytochrome P450 (CYP) enzymes, mainly by
the CYP4A and CYP4F isoforms in the kidney, heart, liver, brain,
lung, and vasculature [1,8–10]. In the vasculature, 20-HETE causes
vasoconstriction in several vascular beds, including renal, cerebral,
aortic, mesenteric, and coronary arteries [11–15]. Activation of
protein kinases, such as mitogen-activated protein kinase (MAPK),following administration of saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) to
1 h after administration of saline or LPS. Data are expressed as means ± S.E.M. of 10
line (vehicle) (p < 0.05). bSigniﬁcant difference from the corresponding value seen in
seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05). dSigniﬁcant difference
1 h value within a group (p < 0.05).
20 B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41MAPK kinase (MEK), and extracellular signal-regulated kinase
(ERK) which contribute to the regulation of vascular tone, have
been shown to mediate the vasoconstrictor effect of 20-HETE
[16–18]. As opposed to its vasoconstrictor effect, 20-HETE has also
been reported to produce vasodilation in the vasculature including
renal and coronary arteries [19–21]. These vasodilatory responses
of 20-HETE have been attributed to NO release [22], conversion
of 20-HETE to 20-OH-PGE2 and 20-OH-PGF2a by COX [13,19,23],
and increased formation of PGE2 [23] and PGI2 [19–21,23]. In addi-
tion, 20-HETE has been shown to activate nuclear factor-jB (NF-
jB) signaling and induce expression of cellular adhesion molecules
and cytokines, thereby promoting inﬂammation [24,25]. CYP4A-
and CYP4F-derived 20-HETE is also involved in LPS-induced acute
systemic inﬂammation as a proinﬂammatory mediator [26,27]. InFig. 2. Effects of 5,14-HEDGE and 20-HEDE on changes in iNOS mRNA expression in (A) k
after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats.
administration of saline or LPS. iNOS mRNA expression in tissue homogenates was me
difference from the corresponding value seen in rats treated with saline (p < 0.05).addition, it has been reported that NO inhibits renal CYPx-hydrox-
ylase activity and the production of 20-HETE [28,29]. Moreover, a
NO-induced fall in the endogenous production of 20-HETE has also
been found to contribute to the cGMP-independent vasodilator ef-
fects of NO in renal and cerebral microcirculations [28,30].
Because of the divergent effects of the NO and eicosanoids in
the regulation of vascular tone and inﬂammation, changes in
the functional balance between the production of these media-
tors might contribute to the pathogenesis and progression of
inﬂammatory diseases, such as sepsis and septic shock. Our pre-
vious studies with the use of a stable synthetic analog of
20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, 5,14-
HEDGE, which mimics the effects of endogenously produced
20-HETE, and a competitive antagonist of vasoconstrictor effectsidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured 4 h
5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
asured by RT-PCR. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41 21of 20-HETE, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid, 20-HEDE,
in cardiovascular and/or renal tissues of rats suggested that in-
creased expression and/or activity of soluble epoxide hydrolase
(sEH) and MEK1/ERK1/2/IjB kinase (IKK) b/inhibitor of jB
(IjB)-a/NF-jB pathway as well as formation of NO and vasodila-
tor prostanoids (i.e., PGI2 and PGE2) by iNOS and COX-2, respec-
tively, peroxynitrite by nicotinamide adenine dinucleotide
phosphate (NADPH) oxidases, and proinﬂammatory cytokines
(i.e., tumor necrosis factor [TNF]-a and interleukin [IL-8]) associ-
ated with decreased CYP2C23 expression and production of anti-
inﬂammatory mediators (i.e., epoxyeicosatrienoic acids; EETs)
contributes to hypotension, tachycardia, inﬂammation, and mor-
tality in a rodent model of septic shock [31–35]. Therefore, the
present study was conducted to determine whether decreasedFig. 3. Effects of 5,14-HEDGE and 20-HEDE on changes in iNOS protein expression in (A) k
after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5
administration of saline or LPS. Immunoprecipitation was performed with anti-iNOS anti
immunoblotting studies. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
bSigniﬁcant difference from the corresponding value seen in the rats treated with LPS (pexpression and activity of iNOS, sGC, PKG, COX-2, gp91phox,
and p47phox, and peroxynitrite production associated with in-
creased expression of COX-1 and CYP4A1 and formation of 20-
HETE in renal and cardiovascular tissues of rats contributes to
the effect of 5,14-HEDGE to prevent vasodilation, hypotension,
tachycardia, and inﬂammation in LPS-treated rats. The results
of this study have been presented in abstract form [33,34].
Materials and methods
Endotoxic shock model
Experiments were performed on Wistar rats (male; 250–330 g;
n = 72) (Research Center of Experimental Animals, Mersinidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured 4 h
,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
body and immunoprecipitated fractions were incubated with anti-iNOS antibody in
difference from the corresponding value seen in rats treated with saline (p < 0.05).
< 0.05).
22 B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41University, Mersin, Turkey) fed a standard chow. They were syn-
chronized by maintenance of controlled environmental conditions
throughout the experiments. The circadian rhythmicity of the ani-
mals was entrained by a standardized 12 h light and 12 h dark cy-
cle. All experiments were carried out according to the National
Institutes of Health Guide for the Care and Use of Laboratory Ani-
mals. The protocol was approved by the Ethics Committee of Mer-
sin University School of Medicine. Endotoxic shock was induced in
rats and mice as previously described by Tunctan et al. [36,37].
Rats were randomly divided into saline (n = 12), LPS (n = 12),
5,14-HEDGE (n = 12), LPS + 5,14-HEDGE (n = 12), 20-HEDE
(n = 12), and LPS + 5,14-HEDGE + 20-HEDE (n = 12) groups [32]. In
the saline, 5,14-HEDGE, and 20-HEDE groups, animals receivedFig. 4. Effects of 5,14-HEDGE and 20-HEDE on changes in iNOS-hsp90 complex format
measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to consci
after administration of saline or LPS. Immunoprecipitation was performed with anti-i
antibody in immunoblotting studies. Data are expressed as means ± S.E.M of 4 animals. a
(p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated w
rats treated with LPS and 5,14-HEDGE (p < 0.05).saline (4 ml/kg, i.p.) at time 0. Animals in the LPS, LPS + 5,
14-HEDGE, and LPS + 5,14-HEDGE + 20-HEDE groups were treated
with LPS (Escherichia coli LPS, O111:B4; Sigma Chemical Co., St.
Louis, MO, USA) (10 mg/kg, i.p.; sublethal dose) at time 0. In the
5,14-HEDGE, LPS + 5,14-HEDGE, and LPS + 5,14-HEDGE + 20-HEDE
groups, animals were treated with a stable synthetic analog of
20-HETE, 5,14-HEDGE (30 mg/kg, s.c.) [32] and/or a competitive
antagonist of vasoconstrictor effects of 20-HETE, 20-HEDE
(30 mg/kg, s.c.) [32]1 h after injection of saline or LPS, respectively.
5,14-HEDGE and 20-HEDE were synthesized in the Department of
Biochemistry University of Texas Southwestern Medical Center,
Dallas, Texas, US. Mean arterial pressure (MAP) and heart rate
(HR) of the rats were measured using a tail-cuff device (MAYion in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery
ous rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h
NOS antibody and immunoprecipitated fractions were incubated with anti-hsp90
Signiﬁcant difference from the corresponding value seen in rats treated with saline
ith LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the
Fig. 5. Effects of 5,14-HEDGE and 20-HEDE on changes in NOS activity in (A) serum, (B) kidney, (C) heart, (D) thoracic aorta, (E) superior mesenteric artery measured 4 h after
saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. NOS activity in sera and tissue homogenates was measured by the rate of L-arginine to nitrite/nitrate conversion using the Ultrasensitive
Colorimetric Assay for Nitric Oxide Synthase ELISA Kit following the manufacturer’s instructions. Data are expressed as means ± S.E.M of 4–6 animals. aSigniﬁcant difference
from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated with LPS (p < 0.05).
cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
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Fig. 6. Effects of 5,14-HEDGE and 20-HEDE on changes in cGMP levels in (A) serum, (B) kidney, (C) heart, (D) thoracic aorta, and (E) superior mesenteric artery measured 4 h
after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. cGMP levels in sera and tissue homogenates were measured by the Cyclic GMP EIA Kit following the manufacturer’s instructions. Data are
expressed as means ± S.E.M of 4–6 animals. aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the
corresponding value seen in the rats treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE
(p < 0.05).
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Fig. 7. Effects of 5,14-HEDGE and 20-HEDE on changes in p-VASP (Ser239) protein expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery
measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h
after administration of saline or LPS. p-VASP (Ser239) protein levels in tissue homogenates were measured by immunoblotting. Data are expressed as means ± S.E.M of 4
animals. aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats
treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41 259610 Indirect Blood Pressure Recorder System, Commat Ltd.,
Ankara, Turkey) during a control period at time 0 and 1, 2, 3, and
4 h. All rats survived in the experiments. Rats were euthanized
4 h after the administration of saline or LPS, and blood sample,
kidney, heart, thoracic aorta, and superior mesenteric artery were
collected from all animals. Detailed method about preparation of
serum and tissue samples is reported in the Supplementary
material.
Messenger ribonucleic acid (mRNA) isolation and reverse
transcription-polymerase chain reaction (RT-PCR)
Complementary deoxyribonucleic acids (cDNAs) for iNOS, COX-
1, COX-2, CYP4A1, b-actin, a-skeletal actin, and a-smooth muscle
actin were synthesized followed by mRNA isolation from the fro-
zen tissue powders as given in detail in the Supplementary
material.Immunoblotting
Immunoblotting for iNOS, heat shock protein (hsp90), phos-
phorylated VASP (p-VASP), COX-1, COX-2, CYP4A1, gp91phox,
p47phox, nitrotyrosine, b-actin, a-sarcomeric actin, and a-smooth
muscle actin proteins were performed according to the method re-
ported in the Supplementary material.
Measurement of NOS, COX, sGC, and CYP hydroxylase activities and
nitrotyrosine levels
NOS, COX, and sGC activities and nitrotyrosine levels in the sera
and tissue samples were measured by enzyme-linked immunosor-
bent assay (ELISA) according to the manufacturer’s instructions in
Ultrasensitive Colorimetric Assay for Nitric Oxide Synthase (Oxford
Biomedical Research Inc., Oxford, MI, USA), Cyclic GMP Enzyme
Immunoassay Kit (Cayman Chemical, Ann Arbor, MI, USA),
Fig. 8. Effects of 5,14-HEDGE and 20-HEDE on changes in COX-1 mRNA expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured 4 h
after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. COX-1 mRNA expression in tissue homogenates was measured by RT-PCR. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated with LPS
(p < 0.05).
26 B. Tunctan et al. / Nitric Oxide 33 (2013) 18–416-keto-PGF1a ELISA Kit (Cayman Chemical Co., Ann Arbor, MI, USA),
PGE2 ELISA Kit (Cayman Chemical Co., Ann Arbor, MI, USA), and
nitrotyrosine ELISA Kit (Northwest Life Science Specialities, LSS,
Vancouver, WA, USA), respectively. As an index for CYP hydroxy-
lase activity, the capacity of renal microsomes to produce 20-HETE
from (14C)-AA was determined as described in the Supplementary
material.Statistical analysis
Data are expressed as means ± S.E.M. Data were analyzed by
one-way ANOVA followed by Student–Newman–Keuls test for
multiple comparisons, Kruskal–Wallis test followed by Dunns test
for multiple comparisons and Student’s t or Mann–Whitney U testswhen appropriate. A P value <0.05 was considered to be statisti-
cally signiﬁcant.Results
Effect of 5,14-HEDGE on the cardiovascular response to LPS
LPS caused a gradual fall in MAP (Fig. 1A) and an increase in HR
(Fig. 1B) over the 4 h course of the experiment (p < 0.05). The
change in MAP and HR reached a maximum 4 h after the adminis-
tration of LPS. MAP fell by 28 mmHg (Fig. 1A) and HR rose by
47 bpm (Fig. 1B) in rats treated with LPS. A synthetic analog of
20-HETE, 5,14-HEDGE, which mimics the effects of endogenously
produced 20-HETE, prevented the fall in MAP (Fig. 1A) and the
Fig. 9. Effects of 5,14-HEDGE and 20-HEDE on changes in COX-1 protein expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured
4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. COX-1 protein levels in tissue homogenates were measured by immunoblotting. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
difference from the corresponding value seen in rats treated with saline (p < 0.05).
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antagonist of the vasoconstrictor effects of 20-HETE, 20-HEDE, re-
versed the ability of 5,14-HEDGE to oppose the effects of endotoxin
on MAP (Fig. 1A) and HR (Fig. 1B) (p < 0.05). 5,14-HEDGE or 20-
HEDE had no effect on MAP (Fig. 1A) or HR (Fig. 1B) in rats treated
with vehicle (p > 0.05).
Effect of 5,14-HEDGE on LPS-induced increase in iNOS expression,
iNOS-hsp90 complex formation, and NOS activity
To determine the effect of 5,14-HEDGE on LPS-induced
changes in iNOS expression and activity, expression of iNOS
mRNA and protein as well as iNOS-hsp90 complex formation
and NOS activity (as indexes for iNOS activity) was measured
in the serum, kidney, heart, thoracic aorta, and/or superiormesenteric artery of endotoxemic rats. LPS increased expression
of iNOS mRNA (Fig. 2) and protein (Fig. 3) as well as iNOS-hsp90
complex formation (Fig. 4) in the kidney, heart, thoracic aorta,
and superior mesenteric artery, and NOS activity in the sera
and renal and cardiovascular tissues (Fig. 5) (p < 0.05). 5,14-
HEDGE prevented the increase in iNOS protein (Fig. 3), but not
mRNA (Fig. 2), expression, iNOS-hsp90 complex formation
(Fig. 4), and NOS activity (Fig. 5) in the sera and/or tissues of
rats caused by LPS (p < 0.05). 20-HEDE reversed the effect of
5,14-HEDGE on iNOS-hsp90 complex formation (Fig. 4) and
NOS activity (Fig. 5), but not mRNA (Fig. 2) and protein
(Fig. 3) expression, in LPS-treated rats (p < 0.05). 5,14-HEDGE
or 20-HEDE had no effect on the basal iNOS expression
(Fig. 3), iNOS-hsp90 complex formation (Fig. 4), and NOS activity
(Fig. 5) in vehicle-treated rats (p > 0.05).
Fig. 10. Effects of 5,14-HEDGE and 20-HEDE on changes in COX-2 mRNA expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured
4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. COX-2 mRNA expression in tissue homogenates was measured by RT-PCR. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated with LPS
(p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
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To determine the effect of 5,14-HEDGE on LPS-induced vascular
hyporeactivity, cGMP levels (as an index for sGC activity) were
measured in the serum, kidney, heart, thoracic aorta, and superior
mesenteric artery of endotoxemic rats. LPS increased cGMP levels
in the serum (Fig. 6A), kidney (Fig. 6B), heart (Fig. 6C), thoracic aor-
ta (Fig. 6D), and superior mesenteric artery (Fig. 6E) (p < 0.05). The
increase in cGMP levels in the sera (Fig. 6A) and tissues (Fig. 6B–E)
of rats caused by LPS was prevented by treatment with 5,14-
HEDGE (p < 0.05). 20-HEDE reversed the effect of 5,14-HEDGE on
cGMP levels in LPS-treated rats (p < 0.05) (Fig. 6). 5,14-HEDGE or
20-HEDE had no effect on the basal cGMP levels in vehicle-treated
rats (p > 0.05) (Fig. 6).Effect of 5,14-HEDGE on LPS-induced increase in PKG activity
To determine the effect of 5,14-HEDGE on LPS-induced vas-
cular hyporeactivity, p-VASP protein expression (as an index
for PKG activity) was measured in the kidney, heart, thoracic
aorta, and superior mesenteric artery of endotoxemic rats. LPS
increased p-VASP protein expression in the kidney (Fig. 7A),
heart (Fig. 7B), thoracic aorta (Fig. 7C), and superior mesenteric
artery (Fig. 7D) (p < 0.05); this increase was prevented by
5,14-HEDGE (p < 0.05) (Fig. 7). 20-HEDE reversed the effect of
5,14-HEDGE on p-VASP protein expression in LPS-treated rats
(p < 0.05) (Fig. 7). 5,14-HEDGE or 20-HEDE had no effect on
the basal p-VASP protein expression in vehicle-treated rats
(p > 0.05) (Fig. 7).
Fig. 11. Effects of 5,14-HEDGE and 20-HEDE on changes in COX-2 protein expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured
4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. COX-2 protein levels in tissue homogenates were measured by immunoblotting. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated with LPS
(p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
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To determine the effect of 5,14-HEDGE on LPS-induced
changes in COX-1 and COX-2 expression and COX activity, expres-
sion of COX-1 and COX-2 mRNA as well as 6-keto-PGF1a and PGE2
levels (as indexes for COX activity) was measured in the serum,
kidney, heart, thoracic aorta, and/or superior mesenteric artery
of endotoxemic rats. LPS decreased expression of COX-1 mRNA
(Fig. 8) and protein (Fig. 9) in the kidney, heart, thoracic aorta,
and superior mesenteric artery while expression of COX-2 mRNA
(Fig. 10) and protein (Fig. 11) was increased in the renal and car-
diovascular tissues (p < 0.05). The LPS-induced increase in COX-2
expression (Figs. 10 and 11) was associated with an increase in6-keto-PGF1a (Fig. 12) and PGE2 (Fig. 13) levels in the kidney,
heart, thoracic aorta, and superior mesenteric artey (p < 0.05).
The decrease in COX-1 mRNA (Fig. 8), but not protein (Fig. 9),
expression, the increase in COX-2 expression (Fig. 10, Fig. 11)
and prostanoid levels (Figs. 12 and 13) in the tissues of rats pro-
duced by LPS was prevented by 5,14-HEDGE (p < 0.05). 20-HEDE
reversed the effect of 5,14-HEDGE on COX-2 expression (Figs. 10
and 11) and prostanoid levels (Figs. 12 and 13), but not COX-1
expression (Figs. 8 and 9) in LPS-treated rats (p < 0.05). 5,14-
HEDGE or 20-HEDE had no effect on the basal COX-1 mRNA
(Fig. 8) and COX-2 expression (Figs. 10 and 11) (p > 0.05), how-
ever, COX-1 protein expression (Fig. 9) and prostanoid levels
(Figs. 12 and 13) were decreased in the tissues of 5,14-HEDGE-
or 20-HEDE-treated control rats (p < 0.05).
Fig. 12. Effects of 5,14-HEDGE and 20-HEDE on changes in 6-keto-PGF1a levels in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured 4 h
after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. 6-keto-PGF1a levels in tissue homogenates were measured by the 6-Keto-PGF1a ELISA Kit following the manufacturer’s instructions. Data are
expressed as means ± S.E.M of 4 animals. aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the
corresponding value seen in the rats treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE
(p < 0.05).
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and CYP hydroxylase activity
To determine the effect of 5,14-HEDGE on LPS-induced decrease
in CYP4A1 expression and CYP hydroxylase activity during endo-
toxemia, expression of CYP4A1 mRNA and protein as well as the
capacity of renal microsomes to produce 20-HETE from (14C)AA
were measured. LPS decreased expression of CYP4A1 mRNA
(Fig. 14) and protein (Fig. 15) as well as 20-HETE formation in renal
microsomes (p < 0.05) (Fig. 16); these effects of LPS were prevented
by 5,14-HEDGE (p < 0.05) (Figs. 14–16). 20-HEDE reversed the ef-
fect of 5,14-HEDGE on CYP4A1 protein (Fig. 15), but not mRNA
expression (Fig. 14), and 20-HETE formation in LPS-treated rats
(p < 0.05). 5,14-HEDGE or 20-HEDE had no effect on the basal
CYP4A1 expression (Figs. 14 and 15) and 20-HETE formation
(Fig. 16) in vehicle-treated rats (p > 0.05).Effect of 5,14-HEDGE on LPS-induced increase in gp91phox protein
expression
To determine the effect of 5,14-HEDGE on LPS-induced increase
in gp91phox (NOX2; a superoxide producing NOX enzyme), protein
expression of gp91phox and p47phox (organizer subunit of gp91phox)
was measured in the kidney, heart, thoracic aorta, and superior
mesenteric artery of endotoxemic rats. LPS increased expression
of gp91phox (Fig. 17) and p47phox (Fig. 18) in the kidney, heart, tho-
racic aorta, and superior mesenteric artery (p < 0.05); these in-
creases were prevented by treatment with 5,14-HEDGE (p < 0.05)
(Figs. 17 and 18). 20-HEDE reversed the effect of 5,14-HEDGE on
expression of gp91phox (Fig. 17) and p47phox (Fig. 18) in LPS-treated
rats (p < 0.05). 5,14-HEDGE or 20-HEDE had no effect on the basal
expression of gp91phox and p47phox in vehicle-treated rats
(p > 0.05) (Figs. 17 and 18).
Fig. 13. Effects of 5,14-HEDGE and 20-HEDE on changes in PGE2 levels in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured 4 h after saline
(vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after administration of
saline or LPS. PGE2 levels in tissue homogenates were measured by the PGE2 ELISA Kit following the manufacturer’s instructions. Data are expressed as means ± S.E.M of 4
animals. aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats
treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
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To determine the effect of 5,14-HEDGE on LPS-induced increase
in peroxynitrite formation, nitrotyrosine (a stable end-product of
peroxynitrite) levels were measured in the serum, kidney, heart,
thoracic aorta, and superior mesenteric artery of endotoxemic rats.
LPS increased nitrotyrosine protein expression in the kidney
(Fig. 19A), heart (Fig. 19B), thoracic aorta (Fig. 19C), and superior
mesenteric artery (Fig. 19D) (p < 0.05). LPS-induced increase in
nitrotyrosine expression was also associated with enhanced
nitrotyrosine levels in the serum (Fig. 20A), kidney (Fig. 20B), heart
(Fig. 20C), thoracic aorta (Fig. 20D), and superior mesenteric artery
(Fig. 20E) (p < 0.05). The increase in nitrotyrosine levels in the sera
and tissues of rats caused by LPS was prevented by 5,14-HEDGE
(p < 0.05) (Figs. 19 and 20). 20-HEDE reversed the effect of 5,14-
HEDGE on nitrotyrosine levels in LPS-treated rats (p < 0.05)(Figs. 19 and 20). 5,14-HEDGE or 20-HEDE had no effect on the ba-
sal nitrotyrosine levels in vehicle-treated rats (p > 0.05) (Figs. 19
and 20).Discussion
The results of the present study indicate that increased expres-
sion and/or activity of iNOS/sGC/PKG pathway, COX-2, gp91phox,
and peroxynitrite production associated with decreased CYP4A1
expression and 20-HETE formation participate in the decrease in
vascular reactivity, fall in blood pressure, tachycardia, and inﬂam-
mation in rats treated with LPS. These data also demonstrate that
5,14-HEDGE, a 20-HETE mimetic, prevents vascular hiporeactivity,
hypotension, tachycardia, and inﬂammation which may be due to
increased CYP4A1 expression and 20-HETE formation associated
with decreased expression and/or activity of the iNOS/sGC/PKG
Fig. 14. Effects of 5,14-HEDGE and 20-HEDE on changes in CYP4A1 mRNA expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured
4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. CYP4A1 mRNA expression in tissue homogenates was measured by RT-PCR. Data are expressed as means ± S.E.M of 4 animals. aSigniﬁcant
difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated with LPS
(p < 0.05).
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matory mediator production in the rat model of septic shock.
There are several reports suggesting a direct link between AA
metabolites and reactive nitrogen species (e.g., NO and peroxyni-
trite) under physiological and pathophysiological conditions
[1,6,8–10]. The constitutive isoforms of COX and NOS enzymes
play an important role in the regulation of several physiological
states. On the other hand, under inﬂammatory conditions such as
endotoxic shock, the inducible isoforms of these enzymes as well
as the NOX family of reactive oxygen species-generating NADPH
oxidases are expressed in a variety of cells and tissues resulting
in the production of large amounts of prostanoids and NO. In the
present study, we measured changes in the expression and/or
activity of iNOS, sGC, PKG, COX-1, COX-2, CYP4A1, and gp91phox(NOX2) and p47phox, organizer subunit of gp91phox, as well as per-
oxynitrite formation at 4 h after LPS administration. LPS produced
a fall in MAP and an increase in HR within 1 h that was sustained
for 4 h. Administration of 5,14-HEDGE prevented the LPS-induced
fall in blood pressure and increase in HR within 1 h. The effects
of LPS on the expression and/or activity of iNOS, sGC, PKG, COX-
1, COX-2, CYP4A1, gp91phox, and p47phox as well as peroxynitrite
formation, except iNOS mRNA and COX-1 protein expression, were
also prevented by 5,14-HEDGE given 1 h after LPS. One might argue
that vasodilator mediators (e.g., NO and prostanoids) and de-
creased levels of 20-HETE generated from an increased expression
of iNOS and COX-2 following activation of the MEK1/ERK1/2/IKKb/
IjB-a/NF-jB pathway, and decreased expression of CYP4A1,
respectively, contribute to the sustained decrease in blood pressure.
Fig. 15. Effects of 5,14-HEDGE and 20-HEDE on changes in CYP4A1 protein expression in (A) kidney, (B) renal microsomes, (C) heart, (D) thoracic aorta, and (E) superior
mesenteric artery measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg,
s.c.) were given 1 h after administration of saline or LPS. CYP4A1 protein levels in tissue homogenates and renal microsomes were measured by immunoblotting. Data are
expressed as means ± S.E.M of 4 animals. aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the
corresponding value seen in the rats treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE
(p < 0.05).
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Fig. 16. Effects of 5,14-HEDGE and 20-HEDE on changes in 20-HETE formation in
renal microsomes measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/
kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE
(30 mg/kg, s.c.) were given 1 h after administration of saline or LPS. The capacity of
renal microsomes to produce 20-HETE from radiolabeled AA was determined as
described in the Supplementary material. Data are expressed as means ± S.E.M of 4
animals. aSigniﬁcant difference from the corresponding value seen in rats treated
with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in
the rats treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding
value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
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1–2 h after LPS administration, and eNOS and COX-1 expression
are downregulated [38–40]. It is also known that increased NO
production by eNOS is responsible for the fall in blood pressure
within 1 h after LPS administration while iNOS-derived NO is
responsible for the delayed hypotension and vascular hyporeactiv-
ity [40,41]. Compensatory mechanisms, including activation of the
renin-angiotensin-aldosteron system, increased sensitivity of baro-
receptor reﬂex mechanisms, and increased production of endothe-
lin-1 and catecholamines, which are known to activate
phospholipase A2 and cause release of AA from tissue lipids, and re-
sults in prostaglandin synthesis, and also stimulate production of
reactive nitrogen (e.g., NO and peroxynitrite) and oxygen (e.g.,
superoxide) species, have also been reported to be responsible
for the changes in the formation of vasoregulatory molecules that
could contribute to the fall in blood pressure during the early
phase of LPS-induced endotoxemia [38–46]. We have previously
demonstrated that selective inhibition of iNOS with phenylene-
1,3-bis(ethane-2-isothiourea) dihydrobromide (1,3-PBIT) prevents
the fall in MAP, increase in HR, and vascular reactivity to norepi-
nephrine as well as increased sGC and PKG activity associated with
systemic and/or aortic NO and nitrotyrosine production 4 h after
LPS administration to rats [36,47–49]. Recently, we have reported
that an increase in iNOS protein expression is associated with a de-
crease in eNOS and COX-1 protein expression in the renal, cardiac,
and vascular tissues as well as vascular hyporeactivity to norepi-
nephrine in thoracic aorta and superior mesenteric artery 4 h after
LPS administration to rats [31,32,50]. These data suggested that
overproduction of NO by iNOS associated with an increase in sGC
and PKG activity in vascular tissue contributes to the hypotension
and vascular hyporeactivity to norepinephrine 4 h after LPS injec-
tion to rats. In the present study, administration of LPS to rats
caused an increase in mRNA and protein expression of iNOS and
COX-2 as well as a decrease in COX-1 and CYP4A1 mRNA and pro-
tein expression in the kidney, heart, thoracic aorta, and superiormesenteric artery. Increased NOS activity, iNOS-hsp90 complex
formation, protein expression of p-VASP, gp91phox, p47phox, and
nitrotyrosine as well as cGMP, PGI2, PGE2, and nitrotyrosine levels
associated with decreased 20-HETE formation were also observed
in the renal and cardiovascular tissues of LPS-treated rats. There-
fore, the results of the present study, together with above-men-
tioned observations, suggest that the NO, vasodilator prostanoids,
and peroxynitrite could cause a decrease in blood pressure which
is followed by increased expression of iNOS, COX-2, and gp91phox
and decreased expression of CYP4A and 20-HETE formation, result-
ing in a sustained fall in blood pressure and tachycardia. Further-
more, a competitive antagonist of vasoconstrictor effects of 20-
HETE, 20-HEDE, reversed the effects of 5,14-HEDGE, except iNOS
and COX-1 mRNA and protein expression as well as expression of
CYP4A1 mRNA. These ﬁndings also suggest that 20-HEDE is not
only an antagonist of vasoconstrictor effects of 20-HETE, but also
have additional effects on the 5,14-HEDGE-induced changes in
the expression and/or activity of iNOS, COX-2, CYP4A1, and
gp91phox during endotoxemia, for example, it reverses the effects
of 5,14-HEDGE on iNOS-hsp90 association and NOS activity with-
out a change in iNOS mRNA and protein expression leading to
NO production and activation of sGC/PKG pathway resulting in
vascular hyporeactivity and hypotension in LPS-treated rats. In
the present study, 5,14-HEDGE and 20-HEDE also caused a de-
crease in COX-1 protein, but not mRNA, expression as well as ser-
um and tissue levels of 6-keto-PGF1a and PGE2 in vehicle-treated
rats. A possible mechanism by which 20-HEDE decreases COX-1
protein expression and systemic and tissue PGI2 and PGE2 produc-
tion in control rats could be through inhibiting the effects of
endogenously produced 20-HETE on COX-1 protein expression
and prostanoid production. It is also possible that both 5,14-
HEDGE and 20-HEDE might directly inhibit COX-1 protein expres-
sion and activity at posttranslational level leading to decreased
prostanoid levels. However, additional experiments need to be
conducted to demonstrate the validity of this hypothesis.
There are conﬂicting data regarding the effect of LPS on CYP4A
expression and activity. Our previous studies suggested that the
endotoxemia-induced increase in NO production primarily via
iNOS suppresses renal CYP4A expression and activity, and selective
inhibition of iNOS with 1,3-PBIT restores renal CYP4A protein and
activity and MAP presumably due to increased production of AA
metabolites derived from CYP4A [49,51]. The results of the present
study together with our previous ﬁndings using 5,14-HEDGE and
COX inhibitors [31,33,50,52] demonstrate that LPS causes a
decrease in CYP4A1 mRNA and protein expression not only in the
kidney, but also in the heart, thoracic aorta, and superior mesen-
teric artery, together with reduced systemic and tissue levels of
20-HETE. In contrast to our ﬁndings, Anwar-Mohamed et al. [26]
demonstrated that CYP4A1 mRNA expression was increased in
the heart of inﬂamed animals at 6, 12, and 24 h by 400%, 900%,
and 6000%, respectively, after injection of LPS (E. coli LPS,
O127:B8, 1 mg/kg, i.p.) to Sprague–Dawley rats. Similarly, but with
a lower magnitude, renal mRNA expression of CYP4A1 was in-
creased only at 24 h by 100% after injection of LPS (E. coli LPS,
O127:B8, 1 mg/kg, i.p.) to rats. The LPS-induced changes in the
expression of CYP4A1 as well as enhanced expression of TNF-a
and IL-6 genes in cardiac and renal tissues were also associated
with increased production of 20-HETE in the heart microsomes
of inﬂamed animals by 40% ex vivo. The authors suggested that
acute inﬂammation causes alteration in cardiac CYP-mediated AA
metabolism in favor of 20-HETE formation. However, Theken
et al. [27] reported that 20-HETE formation in the kidney, but
not in the heart, decreased 6 or 24 h after injection of LPS (E. coli
LPS, O111:B4, 1 mg/kg, i.p.) to C57BL/6 mice leading to the
conclusion that acute activation of the innate immune response
alters CYP expression and eicosanoid metabolism in an isoform-,
Fig. 17. Effects of 5,14-HEDGE and 20-HEDE on changes in gp91phox protein expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery
measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h
after administration of saline or LPS. gp91phox protein levels in tissue homogenates were measured by immunoblotting. Data are expressed as means ± S.E.M of 4 animals.
aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated
with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41 35tissue-, and time-dependent manner. Thus, the contradiction be-
tween previously published studies and our results could be attrib-
uted to differences in type and strain of animals, dose regimen,
strain of LPS, and time points for measurement of enzyme expres-
sion and activity which might reﬂect the differences in the re-
sponse to LPS treatment.
A chaperone molecule, hsp90, has been identiﬁed as a signaling
molecule in the activation of all the isoforms of NOS [53]. Hsp90
associates with NOS and facilitates its phosphorylation and, there-
by, increases NO production. Vo et al. [54] demonstrated that max-
imal vascular iNOS expression and its function are achieved via the
up-regulation and increased association of eNOS with hsp90, and
that in the absence of functional eNOS, the vascular effects of iNOS
are delayed during rodent endotoxemia. Yoshida and Xia [55] also
reported that hsp90 is an important post-translational modulator
of iNOS in iNOS-transfected cells. On the other hand, there are sev-
eral studies reporting that endotoxin up-regulates iNOS protein,but does not alter basal hsp90 expression in in vitro [56] and
in vivo [57] studies. Recently, Cheng et al. [58] have shown that
20-HETE impairs NO production in vitro and its function in vivo
by inhibiting association of eNOS with hsp90. It has been shown
that increased production of 20-HETE in the vasculature is associ-
ated with endothelial dysfunction and increased vascular tone
which contributes to the development of hypertension in animal
models [59]. At least three different pathways have been suggested
to play a role in these responses including increased vascular
expression of subunits of reduced nicotinamide-adenine dinucleo-
tide phosphate oxidase by 20-HETE, leading to production of
superoxide [60], decreased association of eNOS with hsp90 by
20-HETE, leading to diminished formation of NO and increased for-
mation of superoxide [58,61,62], and increased superoxide produc-
tion directly by 20-HETE in endothelial cells [62]. We have
previously demonstrated that 5,14-HEDGE did not prevent the
LPS-induced decrease in endothelium-dependent relaxations
Fig. 18. Effects of 5,14-HEDGE and 20-HEDE on changes in p47phox protein expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery measured
4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h after
administration of saline or LPS. p47phox protein levels in tissue homogenates were measured by immunoblotting. Data are expressed as means ± S.E.M of 4 animals.
aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated
with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
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artery, although it reversed the effects of LPS on vascular hyporeac-
tivity to norepinephrine and overproduction of NO in the tissues
[32]. More recently, we have demonstrated that the LPS-induced
decrease in CYP4A1 protein expression and 20-HETE formation
was accompanied with increased iNOS protein expression, de-
creased expression of eNOS protein, and prostanoid levels without
alterations in hsp90 expression in the kidney, heart, thoracic aorta,
and/or superior mesenteric artery of endotoxemic rats [31,50].
These effects of LPS, except for eNOS and hsp90 protein expression,
were prevented by 5,14-HEDGE. In the present study, 5,14-HEDGE
inhibited the iNOS, gp91phox, p47phox, and nitrotyrosine protein
expression, iNOS-hsp90 complex formation, and NOS activity as
well as nitrotyrosine levels in the renal and cardiovascular tissues
of rats. Therefore, the results of the present study suggest that
20-HETE impairs NO synthesis and its function by inhibiting
association of iNOS with hsp90 and superoxide formation.The results of the present study together with our previous
observations [31–37,47–51,63–65] suggest that increased CYP4A1
and CYP2C23 expression together with formation of vasoactive
eicosanoids (e.g., 20-HETE) and antiinﬂammatory mediators
(e.g., EETs) associated with suppression of not only MEK1/ERK1/
2/IKKb/IjB-a/NF-jB pathway and production of proinﬂammatory
cytokines (e.g., TNF-a and IL-8), but also iNOS, sGC, PKG, COX-2,
gp91phox, and superoxide formation participate in the effect of
5,14-HEDGE to prevent LPS-induced vascular hyporeactivity,
hypotension, tachycardia, and inﬂammatory response in endo-
toxemic rats and mortality in mice. In addition, it seems that
transcriptional (e.g., gene expression), translational (e.g., mRNA
expression and stability), and posttranslational mechanisms
(e.g., protein expression and stability) as well as changes in en-
zyme activity are involved in the regulation of iNOS, COX-1,
COX-2, and CYP4A1 expression by 5,14-HEDGE in the rodent
model of septic shock. Although our results demonstrated that
Fig. 19. Effects of 5,14-HEDGE and 20-HEDE on changes in nitrotyrosine protein expression in (A) kidney, (B) heart, (C) thoracic aorta, and (D) superior mesenteric artery
measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h
after administration of saline or LPS. Nitrotyrosine protein levels in tissue homogenates were measured by immunoblotting. Data are expressed as means ± S.E.M of 4 animals.
aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant difference from the corresponding value seen in the rats treated
with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and 5,14-HEDGE (p < 0.05).
B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41 375,14-HEDGE directly increases CYP4A1 expression at both tran-
scriptional and posttranscriptional levels and 20-HETE production
in endotoxemic rats, it is also possible that 5,14-HEDGE might in-
crease COX-1 and CYP4A1 expression and activity indirectly by
inhibiting expression of iNOS, COX-2, gp91phox, p47phox, and
nitrotyrosine, and/or decreasing the effects of NO, superoxide,
PGI2, PGE2, 20-HETE, cytokines, and/or transcription factors (e.g.,
NF-jB) on the expression and activity of COX-1 and CYP4A1.
However, additional experiments need to be conducted to dem-
onstrate the validity of the proposed hypothesis. Further charac-
terization of the molecular mechanisms of the effects of 5,14-
HEDGE on iNOS, COX-2, CYP4A1, and gp91phox enzymes will pro-
vide the framework for extension of this work into understanding
the role of AA products in the inﬂammatory response associated
with vascular hyporeactivity, hypotension, tachycardia, inﬂamma-
tion, and mortality during endotoxemia.
In conclusion, the present study provides evidence that endo-
toxin induces expression and/or activity of iNOS/sGC/PKG path-
way, COX-2, and gp91phox associated with decreased CYP4A1
expression and 20-HETE formation during endotoxemia whichmay result in vascular hyporeactivity, hypotension, tachycardia,
inﬂammation, and mortality in the rodent model of septic shock
(Fig. 21). Our ﬁndings also suggest that 5,14-HEDGE, a 20-HETE mi-
metic, prevents vascular hyporeactivity, hypotension, tachycardia,
inﬂammation, and mortality presumably due to increased CYP4A1
expression and 20-HETE formation associated with decreased
expression and/or activity of iNOS/sGC/PKG pathway, COX-2, and
gp91phox leading to decreased vasodilatory and inﬂammatory
mediator production. The current management of septic shock re-
lies on immediate treatment with antibiotics and strong support-
ive care to control hypotension, tachycardia, cardiac output, and
tissue oxygenation to maintain organ function. However, the fail-
ure of conventional therapy is that the pathophysiology of septic
shock is the result of a highly complex set of processes in which
the host response becomes dysregulated and causes cellular dam-
age, tissue damage, and, ultimately, organ failure [1]. In the light of
the important role of 20-HETE in the regulation of renal and car-
diovascular hemostasis as well as inﬂammatory process, further
studies with 20-HETE mimetics in experimental models of endo-
toxemia could provide a novel approach to treat hypotension,
Fig. 20. Effects of 5,14-HEDGE and 20-HEDE on changes in nitrotyrosine levels in (A) serum, (B) kidney, (C) heart, (D) thoracic aorta, and (E) superior mesenteric artery
measured 4 h after saline (vehicle) (4 ml/kg, i.p.) or LPS (10 mg/kg, i.p.) injection to conscious rats. 5,14-HEDGE (30 mg/kg, s.c.) and/or 20-HEDE (30 mg/kg, s.c.) were given 1 h
after administration of saline or LPS. Nitrotyrosine levels in sera and tissue homogenates were measured by the Nitrotyrosine ELISA Kit following the manufacturer’s
instructions. Data are expressed as means ± S.E.M of 4–8 animals. aSigniﬁcant difference from the corresponding value seen in rats treated with saline (p < 0.05). bSigniﬁcant
difference from the corresponding value seen in the rats treated with LPS (p < 0.05). cSigniﬁcant difference from the corresponding value seen in the rats treated with LPS and
5,14-HEDGE (p < 0.05).
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Fig. 21. Schematic diagram showing the involvement of iNOS, sGC, PKG, COX-1, COX-2, CYP4A1, and gp91phox in endotoxin-induced vascular hyporeactivity, hypotension,
tachycardia, and survival based on the results of the present and our previous ﬁndings. Endotoxin, the lipid A part of LPS which is the most potent microbial mediator of the
pathogenesis of sepsis and septic shock, increases iNOS and COX-2 mRNA expression, iNOS, p-VASP, COX-2, gp91phox (NOX2; a superoxide generating NOX enzyme), p47phox
(NOXO2; organizer subunit of gp91phox), and nitrotyrosine protein expression, iNOS-hsp90 complex formation, NOS activity, and levels of cGMP, 6-keto-PGF1a, PGE2, and
nitrotyrosine associated with decreased COX-1 and CYP4A1 mRNA expression, COX-1 protein expression, and 20-HETE levels in renal and cardiovascular tissues leading to
vascular hyporeactivity hypotension, tachycardia, andmortality in the rodent model of septic shock. 5,14-HEDGE, a 20-HETE mimetic, prevents the effects of endotoxin on the
increase in expression of COX-1, COX-2, and CYP4A1 mRNA expression, iNOS, p-VASP, COX-2, CYP4A1, gp91phox, p47phox, and nitrotyrosine protein expression, iNOS-hsp90
complex formation, NOS activity, and levels of cGMP, 6-keto-PGF1a, PGE2, 20-HETE, and nitrotyrosine, and thus, restores blood pressure, prevents tachycardia, and improves
survival during rodent endotoxemia. It should be noted that a competitive antagonist of vasoconstrictor effects of 20-HETE, 20-HEDE, prevents the effects of 5,14-HEDGE on
blood pressure, HR, p-VASP, COX-2, CYP4A1, gp91phox, p47phox, and nitrotyrosine protein expression, iNOS-hsp90 complex formation, NOS activity, and 6-keto-PGF1a, PGE2,
20-HETE, and nitrotyrosine levels in rats treated with LPS. It can be concluded that decreased expression and activity of iNOS, sGC, PKG, COX-2, and gp91phox associated with
increased CYP4A1 expression and activity participate in the protective effect of 5,14-HEDGE against vascular hyporeactivity, hypotension, tachycardia, and mortality in the
rodent model of septic shock. ("), increase; (") decrease.
B. Tunctan et al. / Nitric Oxide 33 (2013) 18–41 39tachycardia, inﬂammation, and mortality which lead to multiple
organ failure and death in septic shock.
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